Literature DB >> 22156642

Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration.

Abdullah Aldahmash1, Walid Zaher, May Al-Nbaheen, Moustapha Kassem.   

Abstract

Human stromal (mesenchymal) stem cells (hMSC) represent a group of non-hematopoietic stem cells present in the bone marrow stroma and the stroma of other organs including subcutaneous adipose tissue, placenta, and muscles. They exhibit the characteristics of somatic stem cells of self-renewal and multi-lineage differentiation into mesoderm-type of cells, e.g., to osteoblasts, adipocytes, chondrocytes and possibly other cell types including hepatocytes and astrocytes. Due to their ease of culture and multipotentiality, hMSC are increasingly employed as a source for cells suitable for a number of clinical applications, e.g., non-healing bone fractures and defects and also non-skeletal degenerative diseases like heart failure. Currently, the numbers of clinical trials that employ MSC are increasing. However, several biological and biotechnological challenges need to be overcome to benefit from the full potential of hMSC. In this current review, we present some of the most important and recent advances in understanding of the biology of hMSC and their current and potential use in therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22156642      PMCID: PMC6087654          DOI: 10.5144/0256-4947.2012.68

Source DB:  PubMed          Journal:  Ann Saudi Med        ISSN: 0256-4947            Impact factor:   1.526


  91 in total

1.  Tissue-engineered bone regeneration.

Authors:  H Petite; V Viateau; W Bensaïd; A Meunier; C de Pollak; M Bourguignon; K Oudina; L Sedel; G Guillemin
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

2.  Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential.

Authors:  Pieternella S in 't Anker; Willy A Noort; Sicco A Scherjon; Carin Kleijburg-van der Keur; Alwine B Kruisselbrink; Rutger L van Bezooijen; Willem Beekhuizen; Roelof Willemze; Humphrey H H Kanhai; Willem E Fibbe
Journal:  Haematologica       Date:  2003-08       Impact factor: 9.941

3.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

Review 4.  Allogenic bone-marrow-derived mesenchymal stem cells transplantation as a novel therapy for systemic lupus erythematosus.

Authors:  Huayong Zhang; Xiaofeng Zeng; Lingyun Sun
Journal:  Expert Opin Biol Ther       Date:  2010-05       Impact factor: 4.388

5.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

6.  Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury.

Authors:  Florian Tögel; Kathleen Weiss; Ying Yang; Zhuma Hu; Ping Zhang; Christof Westenfelder
Journal:  Am J Physiol Renal Physiol       Date:  2007-01-09

7.  Differential expression profiling of membrane proteins by quantitative proteomics in a human mesenchymal stem cell line undergoing osteoblast differentiation.

Authors:  Leonard J Foster; Patricia A Zeemann; Chen Li; Matthias Mann; Ole Nørregaard Jensen; Moustapha Kassem
Journal:  Stem Cells       Date:  2005-10       Impact factor: 6.277

8.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

9.  Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.

Authors:  Kiryo Wakabayashi; Atsushi Nagai; Abdullah Md Sheikh; Yuri Shiota; Dashdemberel Narantuya; Tatsuzo Watanabe; Junichi Masuda; Shotai Kobayashi; Seung U Kim; Shuhei Yamaguchi
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

10.  Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis.

Authors:  Basem M Abdallah; Nicholas Ditzel; Moustapha Kassem
Journal:  Methods Mol Biol       Date:  2008
View more
  23 in total

1.  Estrogen deficiency does not decrease the in vitro osteogenic potential of rat adipose-derived mesenchymal stem cells.

Authors:  Francesca Veronesi; Stefania Pagani; Elena Della Bella; Gianluca Giavaresi; Milena Fini
Journal:  Age (Dordr)       Date:  2014-04-01

2.  Derivation of stromal (skeletal and mesenchymal) stem-like cells from human embryonic stem cells.

Authors:  Amer Mahmood; Linda Harkness; Basem M Abdallah; Mona Elsafadi; May S Al-Nbaheen; Abdullah Aldahmash; Moustapha Kassem
Journal:  Stem Cells Dev       Date:  2012-07-13       Impact factor: 3.272

Review 3.  Salivary gland function, development, and regeneration.

Authors:  Alejandro M Chibly; Marit H Aure; Vaishali N Patel; Matthew P Hoffman
Journal:  Physiol Rev       Date:  2022-03-28       Impact factor: 46.500

4.  Cytocompatibility evaluation of different biodegradable magnesium alloys with human mesenchymal stem cells.

Authors:  J Niederlaender; M Walter; S Krajewski; E Schweizer; M Post; Ch Schille; J Geis-Gerstorfer; Hans Peter Wendel
Journal:  J Mater Sci Mater Med       Date:  2013-12-11       Impact factor: 3.896

5.  Epigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem Cells.

Authors:  Dalia Ali; Rimi Hamam; Musaed Alfayez; Moustapha Kassem; Abdullah Aldahmash; Nehad M Alajez
Journal:  Stem Cells Transl Med       Date:  2016-05-18       Impact factor: 6.940

6.  Osteogenic effects of dedifferentiated fat cell transplantation in rabbit models of bone defect and ovariectomy-induced osteoporosis.

Authors:  Shinsuke Kikuta; Nobuaki Tanaka; Tomohiko Kazama; Minako Kazama; Koichiro Kano; Junnosuke Ryu; Yasuaki Tokuhashi; Taro Matsumoto
Journal:  Tissue Eng Part A       Date:  2013-05-15       Impact factor: 3.845

7.  Adenovirus-mediated bone morphogenetic protein-2 promotes osteogenic differentiation in human mesenchymal stem cells in vitro.

Authors:  Hong Cao; Zhi-Bo Sun; Lei Zhang; Wei Qian; Chun-Yang Li; Xiao-Peng Guo; Ying Zhang
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

8.  Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.

Authors:  José M Díez; Ewa Bauman; Rodrigo Gajardo; Juan I Jorquera
Journal:  Stem Cell Res Ther       Date:  2015-03-13       Impact factor: 6.832

9.  microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells.

Authors:  D Hamam; D Ali; R Vishnubalaji; R Hamam; M Al-Nbaheen; L Chen; M Kassem; A Aldahmash; N M Alajez
Journal:  Cell Death Dis       Date:  2014-10-30       Impact factor: 8.469

Review 10.  Skeletal stem cells and their contribution to skeletal fragility: senescence and rejuvenation.

Authors:  Abdullah Aldahmash
Journal:  Biogerontology       Date:  2015-10-28       Impact factor: 4.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.